220 related articles for article (PubMed ID: 10942160)
1. Impaired vasodilatation response to amrinone in the forearm of patients with congestive heart failure: role of endothelium-derived nitric oxide.
Sakane T; Ishibashi Y; Shimada T; Takahashi N; Sugamori T; Hirano Y; Ohata S; Inoue SI; Nakamura K; Murakami Y
J Cardiovasc Pharmacol; 2000 Aug; 36(2):188-95. PubMed ID: 10942160
[TBL] [Abstract][Full Text] [Related]
2. [Endothelial-derived nitric oxide mediates the peripheral vasodilatory effects of amrinone in humans].
Sakane T; Ishibashi Y; Shimada T; Inoue S; Sugamori T; Hirano Y; Takahashi N; Ohata S; Asanuma T; Kato H; Yoshitomi H; Sano K; Murakami Y; Murakami R
J Cardiol; 1999 Jan; 33(1):13-9. PubMed ID: 10028457
[TBL] [Abstract][Full Text] [Related]
3. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
[TBL] [Abstract][Full Text] [Related]
4. Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation.
Duffy SJ; New G; Harper RW; Meredith IT
Cardiovasc Res; 1999 Aug; 43(3):721-30. PubMed ID: 10690343
[TBL] [Abstract][Full Text] [Related]
5. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
Woodman RJ; Playford DA; Watts GF
Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909
[TBL] [Abstract][Full Text] [Related]
6. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
7. Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm.
Engelke KA; Halliwill JR; Proctor DN; Dietz NM; Joyner MJ
J Appl Physiol (1985); 1996 Oct; 81(4):1807-14. PubMed ID: 8904603
[TBL] [Abstract][Full Text] [Related]
8. Does lipoprotein(a) impair endothelial function?
Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide towards vasodilator effects of substance P and ATP in human forearm vessels.
Shiramoto M; Imaizumi T; Hirooka Y; Endo T; Namba T; Oyama J; Hironaga K; Takeshita A
Clin Sci (Lond); 1997 Feb; 92(2):123-31. PubMed ID: 9059312
[TBL] [Abstract][Full Text] [Related]
10. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway.
Kelm M; Preik-Steinhoff H; Preik M; Strauer BE
Cardiovasc Res; 1999 Mar; 41(3):765-72. PubMed ID: 10435049
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide plays an insignificant role in direct vasodilator effects of calcium channel blockers in healthy humans.
Nakamura M; Arakawa N; Yoshida H; Naganuma Y; Nagano M; Hiramori K
Heart Vessels; 2002 Mar; 16(3):105-10. PubMed ID: 12027232
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure.
Ishibashi Y; Shimada T; Murakami Y; Takahashi N; Sakane T; Sugamori T; Ohata S; Inoue S; Ohta Y; Nakamura K; Shimizu H; Katoh H; Hashimoto M
J Am Coll Cardiol; 2001 Nov; 38(5):1470-6. PubMed ID: 11691525
[TBL] [Abstract][Full Text] [Related]
13. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature.
Dawes M; Chowienczyk PJ; Ritter JM
Br J Pharmacol; 2001 Nov; 134(5):939-44. PubMed ID: 11682440
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor.
Katz SD; Krum H
Am J Cardiol; 2001 May; 87(9):1089-92. PubMed ID: 11348607
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
Fichtlscherer S; Dimmeler S; Breuer S; Busse R; Zeiher AM; Fleming I
Circulation; 2004 Jan; 109(2):178-83. PubMed ID: 14662709
[TBL] [Abstract][Full Text] [Related]
16. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells.
Kimura M; Ueda K; Goto C; Jitsuiki D; Nishioka K; Umemura T; Noma K; Yoshizumi M; Chayama K; Higashi Y
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1403-10. PubMed ID: 17446439
[TBL] [Abstract][Full Text] [Related]
17. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.
Katz SD; Schwarz M; Yuen J; LeJemtel TH
Circulation; 1993 Jul; 88(1):55-61. PubMed ID: 8391403
[TBL] [Abstract][Full Text] [Related]
18. Methodological validity and feasibility of the nitric oxide clamp technique for nitric oxide research in human resistant vessels.
Ueda S; Wada A; Umemura S
Hypertens Res; 2004 May; 27(5):351-7. PubMed ID: 15198483
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9.
Passauer J; Pistrosch F; Lässig G; Herbrig K; Büssemaker E; Gross P; Fleming I
Kidney Int; 2005 May; 67(5):1907-12. PubMed ID: 15840038
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent vasodilator response is augmented in peripheral resistance vessels of patients with vasospastic angina.
Nakamura M; Yoshida H; Arakawa N; Hiramori K
Cardiology; 1999; 92(2):85-92. PubMed ID: 10702649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
